Aspirin Use and Mortality in Women With Ovarian Cancer: A Meta-Analysis
BackgroundAspirin use has been suggested to reduce the incidence of ovarian cancer (OC) in women. However, previous studies regarding the association between aspirin use and mortality in women with OC showed inconsistent results. We aimed to evaluate the association between aspirin use and mortality...
Main Authors: | Xiaxia Man, Baogang Wang, Yuying Tan, Xiaolin Yang, Songling Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-02-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2020.575831/full |
Similar Items
-
Aspirin Use and Common Cancer Risk: A Meta-Analysis of Cohort Studies and Randomized Controlled Trials
by: Lijuan Wang, et al.
Published: (2021-06-01) -
Aspirin inhibits tumor progression and enhances cisplatin sensitivity in epithelial ovarian cancer
by: Jianfeng Guo, et al.
Published: (2021-08-01) -
Could aspirin be a lifesaver for prostate cancer patients in prostate cancer-specific mortality?: an update systematic review and meta-analysis
by: Jiatong Zhou, et al.
Published: (2019-12-01) -
Associations between aspirin use and the risk of cancers: a meta-analysis of observational studies
by: Yan Qiao, et al.
Published: (2018-03-01) -
Efficacy and safety of aspirin as an adjunctive therapy in tubercular meningitis: A systematic review and meta-analysis
by: R. Rohilla, et al.
Published: (2021-04-01)